Previous Article | Next Article ![]()
Infection and Immunity, August 2006, p. 4549-4556, Vol. 74, No. 8
0019-9567/06/$08.00+0 doi:10.1128/IAI.00243-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, and California Institute for Medical Research, San Jose, California,1 Division of Pulmonary Biology and Critical Care Medicine, Children's Hospital Medical Center, Cincinnati, Ohio,2 Veterans Affairs Medical Center, Cincinnati, Ohio,3 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri,4 Department of Medicine, Stanford University School of Medicine, Stanford, California5
Received 14 February 2006/ Returned for modification 18 March 2006/ Accepted 7 May 2006
Alveolar surfactant modulates the antimicrobial function of bronchoalveolar macrophages (BAM). Little is known about the effect of surfactant-associated proteins in bronchoalveolar lavage fluid (BALF) on the interaction of BAM and Blastomyces dermatitidis. We investigated BALF enhancement or inhibition of TNF-
production by BAM stimulated by B. dermatitidis. BAM from CD-1 mice were stimulated with B. dermatitidis without or with normal BALF, surfactant protein A-deficient (SP-A/) or surfactant protein D-deficient (SP-D/) BALF, or a mixture of SP-A/ and SP-D/ BALF. An enzyme-linked immunosorbent assay was used to measure tumor necrosis factor alpha (TNF-
) in culture supernatants. BALFs were standardized in protein concentration. BAM plus B. dermatitidis (BAM-B. dermatitidis) TNF-
production was inhibited
47% by BALF or SP-A/ BALF (at 290 or 580 µg of protein/ml, P < 0.05 to 0.01); in contrast, SP-D/ BALF did not significantly inhibit TNF-
production. If SP-A/ BALF was mixed in equal amounts with SP-D/ BALF, TNF-
production by BAM-B. dermatitidis was inhibited (P < 0.01). Finally, pure SP-D added to SP-D/ BALF inhibited TNF-
production by BAM-B. dermatitidis (P < 0.01). B. dermatitidis incubated with BALF and washed, plus BAM, stimulated 63% less production of TNF-
than did unwashed B. dermatitidis (P < 0.05). SP-D was detected by anti-SP-D antibody on BALF-treated unwashed B. dermatitidis in an immunofluorescence assay (IFA). The BALF depleted by a coating of B. dermatitidis lost the ability to inhibit TNF-
production (P < 0.05). 1,3-ß-Glucan was a good stimulator of BAM for TNF-
production and was detected on B. dermatitidis by IFA. ß-Glucan incubated with BALF inhibited the binding of SP-D in BALF to B. dermatitidis as demonstrated by IFA. Our data suggest that SP-D in BALF binds ß-glucan on B. dermatitidis, blocking BAM access to ß-glucan, thereby inhibiting TNF-
production. Thus, whereas BALF constituents commonly mediate antimicrobial activity, B. dermatitidis may utilize BALF constituents, such as SP-D, to blunt the host defensive reaction; this effect could reduce inflammation and tissue destruction but could also promote disease.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»